Skip to content

Prospective study to develop optimal range of lymph node dissection for esophageal cancer

Prospective study to develop optimal range of lymph node dissection for esophageal cancer - Prospective study to develop optimal range of lymph node dissection for esophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042410
Enrollment
30
Registered
2020-11-10
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Local injection of ICG to esophageal submucosa

Sponsors

Department of Surgery, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Planned to undergo esophagectomy for esophageal cancer 2. 20 years old or older 3. No history of iodine allergy 4. No history of ICG allergy 5. Written informed consent to this study

Exclusion criteria

Exclusion criteria: 1. Evaluated not to be appropriate for inclusion by principal investigator

Design outcomes

Primary

MeasureTime frame
Range of lymphatic flow visualized by ICG during esophagectomy

Countries

Japan

Contacts

Public ContactSatoru Matsuda

Keio University School of Medicine Department of Surgery

s.matsuda.a8@keio.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026